Status:
COMPLETED
Time Course Change in Skeletal Muscle and Blood Phospholipid Composition With Omega-3 Fatty Acid Supplementation
Lead Sponsor:
Dr. Chris McGlory, PhD
Conditions:
Skeletal Muscle Fatty Acid Metabolism
Eligibility:
All Genders
19-30 years
Phase:
NA
Brief Summary
Increased omega-3 fatty acid composition of human skeletal muscle phospholipids is linked to improved skeletal muscle strength and growth in women and men. However, what is unknown is if biological se...
Detailed Description
Previous work has shown that supplementing with omega-3 fatty acids leads to increased omega-3 fatty acid composition of skeletal muscle phospholipids. This increase in skeletal muscle omega-3 fatty a...
Eligibility Criteria
Inclusion
- Males and females 19-30 years
- BMI between 18-29 kg/m2
- Free of musculoskeletal injuries
- Participants not currently pregnant
- Participants willing to maintain current use of contraceptives or post-menopausal supplementation if any for the duration of the study.
- Not allergic to fish
- COVID-19 vaccinated to comply with Queen's University's return to campus guidelines, unless exempt by reasons from the Ontario Human Rights Code
- Recreationally active
Exclusion
- Any muscular, neurological, respiratory or metabolic disease including diabetes
- Any form of cancer currently or in the last 5 years
- Currently taking fish oil supplements
- Currently taking any form of steroid
- Consuming \>2 oily fish meals per week
- Pregnant
- Any current illness
- Any current/past lower limb injury/surgery
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 13 2025
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT05971147
Start Date
August 1 2023
End Date
January 13 2025
Last Update
January 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Kinesiology and Health Studies
Kingston, Ontario, Canada, K7L 3N6